Company Analysis

Femasys Inc. (FEMY)

Nasdaq: FEMY · Surgical & Medical Instruments & Apparatus · Suwanee, GA · filing with the SEC since 2005
Grade4.2
◀ Past 3.8● Present 2.7▶ Future 6.6
1 est.

The grade of Femasys Inc.

Nine metrics read from its own filings, by tense
Headline grade
4.2/10
◀ Past3.830% of the headline
● Present2.740% of the headline
▶ Future6.630% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.8/1030% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
3.8/10

Has it survived what it has been through?

6 warning events since 2017; the latest 2026-01-15.

weight 33% of this tense · 38th percentile among 121 sector filers · read for itself

From the record

Femasys Inc.'s filings since 2017 show 6 warning events: a notice about its exchange listing (8-K item 3.01, 6 times, the latest 2026-01-15) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
4.3/10

What has it actually done, year after year?

+17.2% a year over 6 filed years; profitable in 0 of 6.

weight 45% of this tense · 43rd percentile among 105 sector filers · read for its customers

From the record

Femasys Inc.'s 6 filed years say what it did: revenue went from $1 million in fiscal 2020 to $2 million in fiscal 2025, up 17.2% a year; it rose in 4 of 5 years; the deepest fall was 11% from fiscal 2022 to fiscal 2023; net income was positive in 0 of 6 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span17.2%top 46% of its family
  • the share of years revenue rosetop 50% of its family
  • the share of filed years with a profitbottom 23% of its family
  • the deepest fall from a revenue peak11.1%bottom 45% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
2.6/10

How has it treated the people who own it?

SI estimate 2.6/10, confidence 35 of 100 (one part).

weight 22% of this tense · 26th percentile among 120 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 26% of 120 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 120 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Femasys Inc.'s shareholder treatment is put at 2.6 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 26% of 120 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

2.7/1040% of the headline grade · 3 of 3 filed

Financial health

as filed
1.8/10

Is it financially healthy right now?

ROE -317%: lost 317¢ per shareholder dollar. Leverage 72%: owes 72¢ per asset dollar.

weight 45% of this tense · 18th percentile among 120 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Femasys Inc. lost about 317 cents for every dollar of shareholders' money, and gross profitability: its products earned about 7 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 72 cents per dollar of assets, and net share issuance: its share count grew 77.6% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 23% of its family
  • return on equitybottom 10% of its family
  • gross profit against assetsbottom 15% of its family
  • the share count against the year beforebottom 24% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
3.1/10

How strong is its position in its industry?

bottom 31% of 109 in its family; net margin -812.3%.

weight 33% of this tense · 31st percentile among 109 sector filers · read for its customers

From the record

Femasys Inc.'s standing among 109 graded names in its industry family: revenue of $2 million in fiscal 2025 ranks in the bottom 13% by size; a net margin of -812.3% ranks in the bottom 12%; revenue growth of 23.9% a year over the last 3 filed years ranks in the top 30% (its annual reports).

What it rests on

  • revenue against the family$2.3Mbottom 13% of its family
  • net margin-812.3%bottom 12% of its family
  • three-year revenue growth23.9%top 30% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
3.9/10

What are the people in charge doing?

bottom 39% of 91 in its family for leadership; chief executive since 2021.

weight 22% of this tense · 39th percentile among 91 sector filers · read for its shareholders

From the record

Femasys Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Lee-Sepsick, Kathy (Chief Executive Officer, as filed), filing under that title since 2021-06-17, 5.4 years (top 45% of its family); the 11 officers and directors filing in the last fifteen months have been on the record a median of 3 years (bottom 13%); 6 officer or director changes were reported on Form 8-K since 2023-11-13, against the 11 people in charge now (bottom 49%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge6 in three years among 11 peoplebottom 49% of its family
  • the median years the people in charge have filed3.0 yearsbottom 13% of its family
  • the chief executive's years on the record5.4 yearstop 45% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

6.6/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed
5.9/10

How much room does it have to grow?

top 41% of 104 in its family for room to expand.

weight 45% of this tense · 59th percentile among 104 sector filers · read for itself

From the record

Femasys Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $9 million against no long-term debt tagged leaves 44.7% of its assets as net cash, top 20% of its family; cash from operations less capital spending is -837.9% of revenue (bottom 9%); a gross margin of 62% (top 48%); research spending of 330.4% of revenue (top 7%) (its annual report).

What it rests on

  • cash less debt against assets44.7%top 20% of its family
  • cash from operations less capital spending against revenue-837.9%bottom 9% of its family
  • gross margin62.0%top 48% of its family
  • research spending against revenue330.4%top 7% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
7.3/10

What could actually drive growth from here?

top 26% of 105 in its family for growth drivers.

weight 33% of this tense · 74th percentile among 105 sector filers · read for its customers

From the record

Femasys Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 23.9% a year over the last three filed years against 17.2% over all 6, speeding up (top 15% of its family); the newest year grew 40.8% (top 14%); research spending grew 9.2% a year (top 38%); capital spending grew 8.8% a year (top 39%) (its annual reports). Femasys Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • three-year growth against the whole span+6.7 points a yeartop 15% of its family
  • the newest year's revenue growth40.8%top 14% of its family
  • three-year growth of research spending9.2%top 38% of its family
  • three-year growth of capital spending8.8%top 39% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
7.0/10

Did its newest year beat what its own record pointed to?

top 30% of 88 in its family for expectations against reality.

weight 22% of this tense · 70th percentile among 88 sector filers · read for its shareholders

From the record

Femasys Inc.'s newest year against its own record: revenue of $2 million in fiscal 2025 came in 21.1% above the $2 million its prior three years' pace pointed to (top 8% of its family); net income of $19 million against a prior three-year average of $15 million (bottom 26%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 7%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace21.1%top 8% of its family
  • net income against the prior three years' average-26%bottom 26% of its family
  • net margin against its prior averageup more than 100 pointstop 7% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton FEMY · research, not advice